The SAPIEN 3 Ultra valve:

Built for now and what's next

Register for EuroPCR 2023

This year we’re looking towards the future of TAVI as well as marking new milestones in our Edwards Benchmark Program.

Edwards Lifesciences will present the TNT session:

18 May, 13:30-15:00 Paris time (UTC+2) in the Room Maillot

TAVI and patient pathway optimisation – Lifetime management decisions today for challenges of the future!

Join us to:

  • Understand the results of the BENCHMARK registry and how the learnings can be connected to a successful long-term monitoring, increased quality of life and reduced risks for patients
  • Reflect on future challenges after TAVI in patients with longer-life expectancy
  • Be prepared to assess the feasibility of re-do TAVI and to understand what is important in order to find the best treatment strategy
Register Here

Speakers

Prof. Thomas Cuisset
Aphm Hospital La Timone of Marseille
Anchorperson

Prof. Thomas Modine
CHU de Bordeaux
Moderator

Dr. Mirvat Alasnag
King Fahd Armed Forces Hospital - Jeddah
Chatmaster

Prof. Francesco Saia
University Hospital of Bologna
Speaker

Gemma McCalmont
James Cook Hospital - Middlesbrough
Speaker

Dr. Janarthanan Sathananthan
Vancouver General and St Paul’s hospital
Speaker

Prof. Richard Anderson
Spire Cardiff Hospital
Speaker

Prof. Giuseppe Tarantini
University Hospital of Padua
Speaker

Visit our booth at F11 to:

  • Discuss challenging TAVI cases and your future patients needs
  • Experience our 2nd annual silent disco
  • Catch up with the Edwards Lifesciences team over an espresso
Mitral and tricuspid solutions

Discover Edwards SAPIEN 3 Ultra valve

Visit the Edwards Lifesciences SAPIEN 3 valve page to learn more about the Edwards SAPIEN 3 and Edwards SAPIEN 3 Ultra valves.

Explore the valve

Sign up now to receive copies of Edwards Lifesciences recorded event sessions post event, as well as receive event and news informations from Edwards Lifesciences, including:

Publications

Featuring the latest cardiology news, clinical trials and real-world evidence in aortic stenosis (AS) management.

Panel discussions

Involving leading cardiologists debating the latest topics in transcatheter aortic valve implantation (TAVI) and AS management.

Conference headlines

Providing insights into the major developments from the latest cardiology events.

Guidelines updates

Highlighting the areas of change within any updated aortic stenosis treatment guidelines.

For professional use. For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for Use (consult eifu.edwards.com where applicable).

PP--EU-6299 v1.0